本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Vir Biotechnology, Inc.

6.12
-0.1700-2.70%
盤後6.120.00000.00%17:48 EDT
成交量:87.66萬
成交額:535.65萬
市值:8.39億
市盈率:-1.60
高:6.26
開:6.22
低:6.01
收:6.29
資料載入中...
2025/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/30

重要事件披露

Form 8-K - Current report
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/01

重要事件披露

Form 8-K - Current report